Inari Medical stock soars to 52-week high of $79.7
Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of NARI, DFS, LBRDA, CCRN to Act Now
Monteverde & Associates PC (the 'M&A Class Action Firm'), has recovered millions of dollars for shareholders and is ...
bovnews4d
Inari Medical Inc (NARI) Stock: Unveiling Its Hidden Strengths
On Tuesday, Inari Medical Inc (NARI) stock saw a decline, ending the day at $79.5 which represents a decrease of $-0.05 or -0.06% from the prior close of $79.55. The stock opened at $79.54 and touched ...
medtechdive4d
AI in medtech is taking off. Here are 4 trends to watch in 2025.
New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Inari Medical, Inc. (NARI)
January 21, 2025) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Inari Medical, Inc. ("Inari Medical") (NASDAQ: NARI) for ...
UBS initiates Penumbra shares with Buy rating, projects 14% revenue CAGR through 2029
UBS initiated coverage on Penumbra (NYSE:PEN), a medical technology company, with a Buy rating and a price target of $305.00.
Fabbaloo6d
The MedTech Merger Shaping the Future: Stryker Acquires Inari Medical for $4.9 Billion
Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...
bovnews6d
What’s Causing Inari Medical Inc (NARI) Stock’s 45.27% Jump Over the Last Six Months?
Oppenheimer has recently initiated Inari Medical Inc (NARI) stock to Outperform rating, as announced on December 17, 2024, according to Finviz. Earlier, on September 18, 2024, Stifel had initiated the ...